At 60, after building 10 companies, I'm starting an AI startup from scratch — and it's the most important (and terrifying) one yet.

Harrow, Inc. is rapidly evolving into a dominant US ophthalmic pharma player, with a 30-fold revenue increase since 2015 and ...

A quick couple of hours, but I think some important updates from the Capital Markets Day that we held last year. We'll kind of take stock of where we are today. We laid out for you some long-term -- ...